4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001192482-20-000435
Options or other derivatives
- Chief Financial Officer acquired 60,479 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Celano Michael · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-28 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +60,479 | 60,479 | D |
Loading xslF345X03/edgar.xml…